Trial intelligence / Profile preview

Clonidine to Prevent Postictal Delirium After ElectroConvulsive Therapy

NCT04828226Phase 4Completed

Sponsor
Insel Gruppe
Start
Apr 2021
Primary completion
May 2026
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of clonidine in delirium, sponsored by Insel Gruppe. Started Apr 2021; status: completed.

02

Drugs

clonidine
03

Conditions

delirium

Beyond the preview

Go deeper on NCT04828226.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04828226.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call